@article{TGH4329,
author = {Chun-Nan Yeh},
title = {Response letter on Micromanagement of drug-resistant advanced gastrointestinal stromal tumors: regorafenib—new ammunition in battling exon 17 mutations},
journal = {Translational Gastroenterology and Hepatology},
volume = {3},
number = {6},
year = {2018},
keywords = {},
abstract = {We thank Eckardt and Klein for their interest in our phase II trial delineating the treatment efficacy of regorafenib in patients with metastatic and/or an unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17 (1). Several issues emerged (2).},
issn = {2415-1289}, url = {https://tgh.amegroups.org/article/view/4329}
}